The Accelerating Cures Institute can guide potential targets, therapeutic agents, or clinical trials to success. NACI collaborates with the NIH-funded Nephrotic Syndrome Study Network (NEPTUNE) to create a comprehensive drug development and clinical trials pipeline.
NACI’s Strategic Advantages
Conduct clinical trials with expertise to ensure completion and success
Launched in 2015, NACI leverages established partnerships with over 15 years of high value experience.
- Multiple experts in trial design and conduct, including nephrology trials in adults and children
- NACI Network of experienced, trial ready sites
- Active patient and provider engagement and education
- Reputable Data Coordinating Center: SABER (37 multi and single center studies, including 17 RCTs)